In 2024, the U.S. Drug Enforcement Administration (DEA) indicated which they plan to reclassify marijuana for a Routine III drug. This rescheduling will acknowledge that cannabis has legitimate health care functions and can help open the door to analysis on other possible therapy uses. The FD